Financial Performance - The company's operating revenue for the third quarter reached ¥383,678,956.75, representing a year-on-year increase of 7.79%[4] - The total profit for the period was ¥12,469,505.02, while the net profit attributable to shareholders was ¥11,777,137.36[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥2,854,496.27, showing a significant recovery compared to a loss of ¥7,314,155.73 in the previous year[4] - The basic and diluted earnings per share for the quarter were both ¥0.07, compared to ¥0.02 for the same period last year[4] - The weighted average return on equity for the quarter was 0.46%, up from 0.11% year-to-date[4] - Total operating revenue for the first three quarters of 2025 was CNY 1,097,176,424.21, a decrease of 2.6% compared to CNY 1,124,063,386.66 in the same period of 2024[18] - Net profit for the first three quarters of 2025 was a loss of CNY 4,931,390.65, an improvement compared to a loss of CNY 27,382,715.42 in the same period of 2024[20] - Basic earnings per share for the first three quarters of 2025 were CNY 0.02, compared to a loss of CNY 0.15 in the same period of 2024[21] - The company reported a total comprehensive income of CNY 516,447.45 for the first three quarters of 2025, a significant improvement from a loss of CNY 32,904,544.79 in 2024[21] Cash Flow and Management - The cash flow from operating activities showed a net outflow of ¥19,948,382.46 year-to-date, indicating challenges in cash management despite revenue growth[4] - The company reported a net cash inflow from operating activities of CNY 883,124,334.62 for the first three quarters of 2025, compared to CNY 935,845,918.78 in 2024, reflecting a decrease of 5.6%[23] - Cash inflow from operating activities decreased to ¥687.95 million from ¥761.47 million, a decline of approximately 9.6% year-over-year[24] - Net cash outflow from operating activities was ¥19.95 million, slightly improved from ¥21.74 million in the previous period[24] - Cash inflow from investment activities totaled ¥1.17 billion, down from ¥1.20 billion, reflecting a decrease of about 1.0%[24] - Net cash outflow from investment activities was ¥61.45 million, an improvement from ¥150.44 million in the prior period[24] - Cash inflow from financing activities increased to ¥821.07 million from ¥737.35 million, representing an increase of approximately 11.3%[24] - Net cash outflow for financing activities was ¥643.50 million, compared to ¥532.85 million previously, indicating a rise of about 20.8%[24] - The ending cash and cash equivalents balance rose to ¥639.74 million from ¥579.09 million, an increase of approximately 10.5%[25] - The company reported a net increase in cash and cash equivalents of ¥98.65 million, compared to ¥36.99 million in the previous period[24] Assets and Liabilities - The company's total assets increased by 4.97% to ¥4,210,550,065.51 compared to the end of the previous year[5] - The company's total current assets as of September 30, 2025, amount to ¥1,786,749,621.18, an increase from ¥1,642,058,832.97 as of December 31, 2024[16] - Total assets as of September 30, 2025, are ¥4,210,550,065.51, up from ¥4,011,278,629.43[17] - Current liabilities increased to ¥1,247,494,026.63 from ¥1,057,395,234.02, showing a rise of approximately 18%[17] - The total liabilities increased to CNY 1,515,197,760.63 in 2025 from CNY 1,353,075,636.87 in 2024, marking an increase of 12%[19] - The total equity attributable to shareholders of the parent company was CNY 2,567,282,106.18, slightly up from CNY 2,556,781,731.64 in 2024[19] Research and Development - Research and development expenses totaled ¥18,274,406.87, accounting for 4.76% of operating revenue, a decrease of 1.09 percentage points from the previous year[5] - Research and development expenses for the first three quarters of 2025 were CNY 54,774,529.44, a decrease of 9.1% from CNY 60,481,355.82 in 2024[20] Shareholder Information - The total number of common shareholders at the end of the reporting period is 12,448[13] - The largest shareholder, Zhao Guofeng, holds 29,459,697 shares, representing 18.27% of total shares[13] Non-Recurring Gains - Non-recurring gains for the period amounted to ¥8,922,641.09, contributing positively to the overall profit[8] Strategic Focus - The company has focused on deepening cooperation with existing customers and expanding its customer base, which has positively impacted profitability[9] Future Considerations - The company plans to implement new accounting standards starting in 2025, which may affect future financial reporting[26]

Fundraising Overview - The company successfully raised a total of RMB 185,415.74 million by issuing 27,806,800 shares at a price of RMB 66.68 per share, with a net amount of RMB 170,929.30 million after deducting issuance costs of RMB 14,486.45 million [1] Changes in Fundraising Projects - The company decided to reallocate RMB 48 million of unused fundraising to two new projects: a 1,500-ton acyl phosphine oxide series photoinitiator project and a 350-ton hydroxy ketone series photoinitiator project, with the approval from the board and shareholders [2][3] Fund Management and Supervision - The company established special fundraising accounts for the new projects and signed a tripartite supervision agreement with the banks and the sponsor to ensure compliance with fundraising management regulations [3][4] - The special accounts are designated solely for the respective projects, ensuring that funds are not used for other purposes [5][9] Agreement Details - The tripartite agreement outlines the responsibilities of each party, including the management of funds, supervision by the sponsor, and the requirement for monthly account statements [6][7] - The agreement will remain effective until all funds are utilized and the supervision period concludes [8][12]

Group 1 - The company Tianjin Jiuri New Materials Co., Ltd. has signed a tripartite supervision agreement for the management of raised funds [1][4] - The company raised a total of RMB 185,415.74 million by issuing 27,806,800 shares at a price of RMB 66.68 per share, with a net amount of RMB 170,929.30 million after deducting issuance costs [2][3] - The company has allocated RMB 48 million of unused raised funds to two new projects: a 1,500-ton acyl phosphine oxide series photoinitiator project and a 350-ton hydroxy ketone series photoinitiator project [3][4] Group 2 - The tripartite supervision agreement was signed on October 17, 2025, involving Tianjin Jiuri, its wholly-owned subsidiary Inner Mongolia Jiuri New Materials Co., Ltd., and the sponsor and bank [4][6] - The agreement stipulates that the funds must be stored in a special account solely for the designated projects and cannot be used for other purposes [6][10] - The sponsor has the right to supervise the use of the raised funds and must conduct semi-annual inspections of the fund management [7][11]

证券代码：688199 证券简称：久日新材 公告编号：2025-060 天津久日新材料股份有限公司 关于签署募集资金三方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意天津久日新材料股份有限公司首次公 开发行股票注册的批复》（证监许可[2019]1887 号），同意公司首次公开发行 股票的注册申请，公司向社会公开发行人民币普通股 2,780.68 万股，每股面值 人民币 1.00 元，每股发行价为人民币 66.68 元，共募集资金人民币 185,415.74 万元，扣除发行费用 14,486.45 万元（不含税），实际募集资金净额为人民币 170,929.30 万元。前述募集资金到位情况经大华会计师事务所（特殊普通合伙） 验证，并出具了《天津久日新材料股份有限公司发行人民币普通股（A 股） 2,780.68 万股后实收股本的验资报告》（大华验字[2019]000423 号）。公司已 对募集资金进行了专户存储，并与保荐机构、存放募集资金的商业银行签署了募 ...

Group 1 - The core viewpoint of the article is that Jiu Ri New Materials (688199.SH) has significantly increased its sales of photosensitive agents in the third quarter of this year compared to the same period last year, indicating a successful scale-up of sales [1] Group 2 - The company has confirmed that its photosensitive agents have now achieved large-scale sales [1]

Core Points - Jiu Ri New Materials experienced a stock price decline of 2.03% on October 17, trading at 23.64 CNY per share with a market capitalization of 3.811 billion CNY [1] - The company has seen a year-to-date stock price increase of 57.08%, but has faced a decline of 14.04% over the last five trading days [1] - The company specializes in photoinitiators, with 79.50% of its revenue coming from this segment [1][2] Financial Performance - For the first half of 2025, Jiu Ri New Materials reported a revenue of 713 million CNY, a year-on-year decrease of 7.11%, while the net profit attributable to shareholders was -9.0573 million CNY, an increase of 29.69% [2] - The company has distributed a total of 203 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [2] Shareholder Information - As of June 30, 2025, the number of shareholders decreased by 3.44% to 10,900, with an average of 14,767 circulating shares per shareholder, an increase of 3.56% [2] - New institutional shareholders include Penghua Quality Governance Mixed Fund, holding 2.1373 million shares, and several others, indicating increased institutional interest [2]

证券代码：688199 证券简称：久日新材 公告编号：2025-059 天津久日新材料股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 投资者可于 2025 年 10 月 20 日（星期一）至 10 月 24 日（星期五）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 （jiuri@jiuri.com.cn）进行提问。公司将在说明会上对投资者普遍关注的问题进 行回答。 天津久日新材料股份有限公司（以下简称公司）将于 2025 年 10 月 25 日发布 公司《2025 年第三季度报告》，为便于广大投资者更全面深入地了解公司 2025 年 第三季度的经营成果、财务状况，公司计划于 2025 年 10 月 27 日（星期一） 10:00-11:00 召开 2025 年第三季度业绩说明会，就投资者关心的问题进行交流。 董事、总裁：解敏雨先生 董事、副总裁（研发负责人）：张齐先生 一、说明会类型 本次业绩说明会以网络互动形式召开 ...

久日新材发行新股募集资金总额为185,415.74万元，募集资金净额为170,929.29万元。久日新材最终募集 资金净额比原计划多11387.21万元。久日新材2019年10月30日发布的招股说明书显示，公司拟募集资金 159,542.08万元，用于年产87,000吨光固化系列材料建设项目、光固化技术研究中心改建项目、补充流 动资金。 久日新材的发行费用总额为14,486.45万元，其中承销费用与保荐费用12,757.02万元。 中国经济网北京10月14日讯久日新材(688199.SH)今日收报25.41元，跌幅6.65%，总市值40.97亿元。目 前该股处于破发状态。 久日新材于2019年11月5日在上交所科创板上市，发行股份数量为2,780.68万股，占发行后总股本的 25%，全部为公开发行新股，发行价格为66.68元/股。久日新材的保荐机构(联席主承销商)为招商证券 股份有限公司，保荐代表人为孙越、刘宪广；联席主承销商为太平洋证券股份有限公司。 根据2024年6月13日披露的《2023年年度权益分派实施公告》，以实施权益分派的股权登记日登记的公 司总股本扣减公司回购专用证券账户中股份为基数分配利润，以 ...

Core Viewpoint - The company has approved the use of part of its raised funds to provide a loan to its controlling subsidiary, which is aimed at implementing a fundraising investment project, thereby enhancing the efficiency of fund utilization [1][4][9]. Meeting Details - The fifth session of the company's supervisory board was held on October 13, 2025, with all three supervisors present, and the meeting complied with relevant laws and regulations [1][2]. - The supervisory board unanimously approved the proposal to use part of the raised funds for the loan [2]. Fundraising and Loan Details - The company plans to provide a loan of 9 million RMB to its subsidiary, Inner Mongolia Hongyuan Tiancheng Technology Development Co., Ltd., for the implementation of a project to produce 350 tons of hydroxy ketone series photoinitiators annually [4][5]. - The total amount raised from the initial public offering was approximately 1.85 billion RMB, with a net amount of about 1.71 billion RMB after deducting issuance costs [5]. Purpose and Impact of the Loan - The loan is intended to ensure the smooth implementation of the fundraising investment project and aligns with the planned use of raised funds, without altering the intended use or harming shareholder interests [9][11]. - The subsidiary, Hongyuan Tiancheng, is financially stable and poses controllable financial risks [9]. Fund Management - The loan will be managed through a dedicated account for raised funds, with a tripartite supervision agreement signed among the company, the bank, and the sponsor [10]. - The loan interest rate will be determined based on the latest published loan market quotation rate and other factors, with a maximum term of 36 months [6]. Opinions from Supervisory Board and Sponsor - The supervisory board and the sponsor have expressed their agreement with the proposal, confirming compliance with relevant regulations and the company's fundraising management system [12].

以实施募投项目的核查意见 招商证券股份有限公司（以下简称"招商证券"、"保荐机构"）作为天津久日 新材料股份有限公司（以下简称"久日新材"、"公司"）首次公开发行股票并在科 创板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上市公司募集 资金监管规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范 运作》等有关法律法规和规范性文件的相关规定，对久日新材使用部分募集资金 向控股孙公司提供借款以实施募投项目事项进行了核查，核查情况如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意天津久日新材料股份有限公司首次公 开发行股票注册的批复》（证监许可[2019]1887 号），同意公司首次公开发行股票 的注册申请，公司向社会公开发行人民币普通股 2,780.68 万股，每股面值人民币 1.00 元，每股发行价为人民币 66.68 元，共募集资金人民币 185,415.74 万元，扣 除发行费用 14,486.45 万元（不含税），实际募集资金净额为人民币 170,929.30 万 元。前述募集资金到位情况经大华会计师事务所（特殊普通合伙）验证，并出具 了《天津久日新材料股份有限公司发 ...